Mar 08, 2022 / 03:30PM GMT
Daniel Gregory Brennan - Cowen and Company, LLC, Research Division - Research Analyst
Good morning. Dan Brennan here. Day 2 of the Cowen Health Care Conference. I'm certainly thrilled to be here, having joined not too long ago and joined here on the virtual stage for this session with Thierry Bernard, the Chief Executive Officer of QIAGEN, who we hosted back in December and really enjoyed our meetings and I'm looking forward to this today.
So first off, Thierry, welcome.
Thierry Bernard - QIAGEN N.V. - CEO, MD & Member of Management Board
Thanks for having us.
Questions and Answers:
Daniel Gregory Brennan - Cowen and Company, LLC, Research Division - Research AnalystYou got it. So I thought I'd have a series of maybe top-down questions to kick it off, and then we'll get into the 5 pillars, and then we'll talk about profitability and maybe end on some strategy things.
But maybe just from a high level to kick it off, Thierry, so your guidance this year calls for north of 10% core business